Biotechnology companies pioneer new drugs and make life better...how ironic their stocks have managed to wreak so much havoc in recent weeks. If you're looking for a culprit behind the selloff, blame biotech. The group's momentum led stocks higher, and now it's payback time.
In the battle between global consumer-health companies for a multi billion dollar foot-care, allergy and sun-tan lotion business, Reckitt Benckiser Group Plc has advantages that rivals will be hard pressed to match.
Pfizer Inc., Eli Lilly & Co. and Novartis AG have dug an idea out of the pharmaceutical dustbin to create new medicines that are showing blockbuster potential against hard-to-treat forms of breast cancer.
GlaxoSmithKline Plc fired some workers and withheld bonuses in China after a corruption investigation begun last year spurred a deeper review of employee expense claims, a person familiar with the matter said.
Bayer AG will have to share more data about the quality of life for patients who take its costly new cancer medicine Stivarga after a request from a German panel that makes coverage decisions for public insurers.